Estimation of the efficiency mesenchymal stem cell secretome using in post-operative corneal sequestrum therapy clinical treatment results

This article summarizes our clinical treatment results for various stages of corneal sequestrum in 24 cats using mesenchymal stem cell secretome (cytokines / growth factors). Our results show that the regenerative drug used in the study had a positive effect on the quality and speed of the corneal regeneration and effectively reduced inflammation during the post-operative period, which contributed to the lack of any rejection of donor cornea.